Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Sang Hoon | - |
dc.contributor.author | Lee, Jung Min | - |
dc.contributor.author | Lee, Hee Ju | - |
dc.contributor.author | Kim, Chul Young | - |
dc.contributor.author | Lee, Eun Ha | - |
dc.contributor.author | Um, Byung Hun | - |
dc.date.accessioned | 2024-01-21T00:35:09Z | - |
dc.date.available | 2024-01-21T00:35:09Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 2007-08 | - |
dc.identifier.issn | 0918-6158 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/134252 | - |
dc.description.abstract | To evaluate active principles for diabetic complications from the black bamboo leaves, Phyllostachys nigra, eight compounds were isolated and tested for their effects on rat lens aldose reductase and advanced glycation endproducts. As a result, luteolin 6-C-(6 ''-O-trans-caffeoylglucoside) was found to show a strong aldose reductase and advanced glycation endproducts inhibition. This compound showed antioxidative activity measured in Photochem (R) apparatus. It is concluded, therefore, that luteolin 6-C-(6 ''-O-trans-caffeoylglucoside) (6), a flavone of this plant, have antioxidative as well as aldose reductase and advanced glycation endproducts inhibitory effects. As a result, this compound could be offered as a leading compound for further study as a new natural products drug for diabetic complications. | - |
dc.language | English | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | STRUCTURAL REQUIREMENTS | - |
dc.subject | PROTEIN GLYCATION | - |
dc.subject | FLAVONOIDS | - |
dc.subject | RAT | - |
dc.subject | COMPLICATIONS | - |
dc.subject | PREVENTION | - |
dc.subject | SORBINIL | - |
dc.title | Aldose reductase and advanced glycation endproducts inhibitory effect of Phyllostachys nigra | - |
dc.type | Article | - |
dc.identifier.doi | 10.1248/bpb.30.1569 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.30, no.8, pp.1569 - 1572 | - |
dc.citation.title | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.volume | 30 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1569 | - |
dc.citation.endPage | 1572 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000249363300039 | - |
dc.identifier.scopusid | 2-s2.0-34548041862 | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | STRUCTURAL REQUIREMENTS | - |
dc.subject.keywordPlus | PROTEIN GLYCATION | - |
dc.subject.keywordPlus | FLAVONOIDS | - |
dc.subject.keywordPlus | RAT | - |
dc.subject.keywordPlus | COMPLICATIONS | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | SORBINIL | - |
dc.subject.keywordAuthor | aldose reductase | - |
dc.subject.keywordAuthor | advanced glycation endproduct | - |
dc.subject.keywordAuthor | phyllostachys nigra | - |
dc.subject.keywordAuthor | luteolin 6-C-(6"-O-trans-caffeoylglucoside) | - |
dc.subject.keywordAuthor | antioxidant | - |
dc.subject.keywordAuthor | diabetic complications | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.